Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
10.22092/ari.2024.367474.3396
Abstract
I read the article by Krishna Kumar et al. which examined B-cell lymphoma/leukemia-2 (Bcl-2) expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma [1].
Jadali, Z. (2025). Expression Analysis of BCL-2 in Endometrial Hyperplasia and Carcinoma: The Powers and Limitations. Archives of Razi Institute, 80(5), 1089-1090. doi: 10.22092/ari.2024.367474.3396
MLA
Jadali, Z. . "Expression Analysis of BCL-2 in Endometrial Hyperplasia and Carcinoma: The Powers and Limitations", Archives of Razi Institute, 80, 5, 2025, 1089-1090. doi: 10.22092/ari.2024.367474.3396
HARVARD
Jadali, Z. (2025). 'Expression Analysis of BCL-2 in Endometrial Hyperplasia and Carcinoma: The Powers and Limitations', Archives of Razi Institute, 80(5), pp. 1089-1090. doi: 10.22092/ari.2024.367474.3396
CHICAGO
Z. Jadali, "Expression Analysis of BCL-2 in Endometrial Hyperplasia and Carcinoma: The Powers and Limitations," Archives of Razi Institute, 80 5 (2025): 1089-1090, doi: 10.22092/ari.2024.367474.3396
VANCOUVER
Jadali, Z. Expression Analysis of BCL-2 in Endometrial Hyperplasia and Carcinoma: The Powers and Limitations. Archives of Razi Institute, 2025; 80(5): 1089-1090. doi: 10.22092/ari.2024.367474.3396
)